Skip to main content
Hester Biosciences Ltd logo

Hester Biosciences Ltd — Investor Relations & Filings

Ticker · HESTERBIO ISIN · INE782E01017 LEI · 984500836B9EB1DC4935 BSE.NS Manufacturing
Open in API
Filings indexed 672 across all filing types
Latest filing 2021-10-28 Regulatory Filings
Country IN India
Listing BSE.NS HESTERBIO

About Hester Biosciences Ltd

https://www.hester.in/

Hester Biosciences Ltd specializes in the development, manufacturing, and marketing of animal healthcare products. The company primarily focuses on two segments: poultry healthcare and livestock healthcare. Its extensive product portfolio includes a wide range of live and inactivated vaccines, as well as health products such as therapeutics, herbal supplements, and disinfectants. Hester is recognized for its significant contributions to global animal disease control programs, particularly in the eradication of Peste des Petits Ruminants (PPR) and Brucellosis. The company operates advanced manufacturing facilities and maintains a robust distribution network to serve domestic and international markets. By leveraging research and development, Hester provides diagnostic services and technical support to enhance animal productivity and welfare. Its commitment to quality and innovation has established it as a key provider of biologicals and health solutions for the veterinary sector.

Recent filings

Filing Released Lang Actions
Outcome of Board Meeting
Regulatory Filings
2021-10-28 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 95% confidence The document is an announcement informing about an upcoming earnings conference call scheduled for October 28, 2021, to discuss the unaudited financial results for the quarter and half year ended September 30, 2021. It includes details about the call, participants, and contact information. The document does not contain actual financial results or detailed analysis but serves as an invitation and notification of the call. Therefore, it is not an earnings release (ER) or interim report (IR) but a call transcript announcement. According to the filing definitions, this fits the category of Call Transcript (CT) as it relates to the earnings conference call event.
2021-10-22 English
Board Meeting — Financial Results
Board/Management Information Classification · 95% confidence The document is a short notice informing stock exchanges about an upcoming Board Meeting scheduled to consider unaudited financial results for a quarter and half year period. It references Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, which governs disclosures related to board meetings. The document does not contain any financial data or results itself, nor does it provide detailed financial analysis or reports. It is an announcement of a board meeting, not the meeting materials or financial results. Therefore, it fits the category of Board/Management Information (MANG), which includes announcements of board meetings and related disclosures.
2021-10-20 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings
2021-10-11 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a notification addressed to stock exchanges about the closure of the trading window in compliance with SEBI regulations related to insider trading. It specifies the trading window closure period around the release of quarterly financial results but does not contain any financial data or results itself. The document is short (1207 characters) and serves as an announcement rather than a report. Therefore, it fits best under Regulatory Filings (RNS), which covers compliance and regulatory announcements that do not fit other categories.
2021-09-30 English
Shareholders meeting
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is dated 17.08.2021 and relates to the 34th Annual General Meeting (AGM) of Hester Biosciences Limited. It includes detailed proceedings of the AGM, including the chairman's speech, resolutions passed, voting procedures, and responses to shareholder queries. Additionally, it contains the Scrutinizer's Report on the remote e-voting process and voting during the AGM, which details the appointment of the scrutinizer, voting timelines, and the final voting results. The document is comprehensive and focused on the AGM event and its outcomes, including voting results. It is not a full annual report, earnings release, or other financial report but specifically the outcome and proceedings of the AGM along with the voting results. Therefore, the document fits best into the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The length (15,000 characters) and detailed content confirm it is not a mere announcement but a full report of voting results and AGM proceedings.
2021-08-17 English

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.